SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-038429
Filing Date
2022-03-28
Accepted
2022-03-28 08:14:53
Documents
14
Period of Report
2022-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210414d1_8k.htm   iXBRL 8-K 27947
2 EXHIBIT 99.1 tm2210414d1_ex99-1.htm EX-99.1 61273
3 GRAPHIC tm2210414d1_ex99-1img005.jpg GRAPHIC 3104
  Complete submission text file 0001104659-22-038429.txt   276409

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA immu-20220328.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20220328_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20220328_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2210414d1_8k_htm.xml XML 3598
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 22773270
SIC: 2834 Pharmaceutical Preparations